Brazilian livestock industry faces EU antimicrobial ban and vaccine import dependence

The European Union will impose an embargo on Brazilian animal‑origin products starting 3 September because of concerns over the use of antimicrobials in livestock. The ban threatens billions of dollars in exports and has prompted a split among Brazilian stakeholders. Large meat‑packing firms, including JBS, have urged President Luiz Inácio Lula to adopt a nationwide prohibition of a broader list of antimicrobials, arguing it would safeguard export markets. In contrast, a coalition of 14 producer organisations, such as Acrimat, Famato, SRB and ABCZ, argues that EU requirements should apply only to animals destined for the EU and that a segregation system – separate production lines for export versus domestic markets – is the proper solution. They warn that codifying foreign commercial rules into national law would jeopardise regulatory sovereignty, increase costs and set a precedent for future external interventions.

At the same time, Brazil remains heavily dependent on imported clostridial vaccines to prevent sudden‑death diseases in cattle. Official data show that 74 % of the 5.44 million doses supplied in July were imported, while only 26 % were produced domestically. The Ministry of Agriculture is seeking to expand local vaccine production and accelerate import clearance to avoid supply gaps, recognising that outbreaks can cause 5‑10 % mortality in a herd and erase profit margins for producers.

Both issues underline the sector’s vulnerability: external market standards and supply‑chain dependencies could shape Brazil’s livestock policies and farm‑level economics in the months ahead.